AzTrials
AzTrials

Dry Eye Syndrome (DES)Phase 2LADESJSNCT06780293

Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)

A Phase 2 study testing Laser acupuncture (LA), Numerical Rating Scale (NRS) and Schirmer's test in people with Dry Eye Syndrome (DES) and Laser Acupuncture, run by Taipei Veterans General Hospital, Taiwan at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy of adding laser acupuncture at Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), and Quchi (LI11) acupoints to standard care for the treatment of dry eye symptoms in both Sjögren's Syndrome-related dry eye (SJS-DES) and… Read more about this study

Who is it for?
Ages 20 to 75 years
What is being tested?
Laser acupuncture (LA), Numerical Rating Scale (NRS) and Schirmer's test
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
140 participants
Where
1 siteTaiwan
Study dates
3 Feb 2025to 31 Dec 2026
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged between 20 and 75 years
  • Schirmer's test less than 10 mm/5 min
  • primary or secondary SS
  • aged between 20 and 75 years
  • fulfilled the 2002 American-European Consensus Criteria for SS (AECG)
  • had no abnormal findings of immune, liver, kidney, or blood function evaluations.

Who cannot join

  • Pregnancy
  • With eye inflammation or infectious eye disease
  • Accepted operation of eye
  • Sjögren's syndrome
  • a history of alcohol abuse, diabetes mellitus, or major life-threatening condition
  • pregnancy or breastfeeding
  • steroid pulse therapy within three months prior to the commencement of our study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ching-Mao Chang, M.D., Ph.D. contact

886-28757453, 333

magicbjp@gmail.com

Taiwan1 site, 1 recruiting
  • Ching-Mao Chang

    Taipei, Taiwan, 886

    Ching-Mao Chang, M.D., Ph.D., 88628757453 ext. 333, magicbjp@gmail.com

    Ching-Mao Chang, M.D., Ph.D.

    Recruiting

Other trials in Taiwan

About this study

Official title: Exploring the Long-term Therapeutic Effects of Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy of adding laser acupuncture at Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), and Quchi (LI11) acupoints to standard care for the treatment of dry eye symptoms in both Sjögren's Syndrome-related dry eye (SJS-DES) and non-Sjögren's Syndrome-related dry eye (Non-SJS-DES) populations. A total of 140 dry eye patients will be recruited and divided into two groups: 70 participants with SJS-DES and 70 with Non-SJS-DES. Participants will be randomly assigned into three groups: Sham+LA group (60 participants receiving 4 weeks of placebo laser acupuncture followed by 4 weeks of active laser acupuncture), LA+LA group (60 participants receiving 4 weeks of active laser acupuncture followed by another 4 weeks of active laser acupuncture), and a Waiting List group (20 participants receiving no laser acupuncture treatment). Each session will target the Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), and Quchi (LI11) acupoints bilaterally, performed twice a week. The total study period is 8 weeks, and the treatment efficacy will be assessed at the end of the 8-week treatment. The Waiting List group (20 participants) will not receive any laser acupuncture treatment during this period. Efficacy will be evaluated using the Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), Traditional Chinese Medicine (TCM) tongue diagnosis, TCM pulse diagnosis, TCM constitution questionnaire, TCM heart rate variability analysis, nailfold microcirculation assessment, and iris examination. This study aims to investigate the impact of laser acupuncture on dry eye symptom improvement and the potential markers that differentiate between SJS-DES and Non-SJS-DES patients. The goal is to develop a comprehensive integrated care model for early screening, diagnosis, and personalized treatment plans for Dry Eye Syndrome and Sjögren's Syndrome, achieving the ultimate objective of "Holistic Health Care."

Read the detailed description

Method: This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy of adding laser acupuncture at Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), and Quchi (LI11) acupoints to standard care for the treatment of dry eye symptoms in both Sjögren's Syndrome-related dry eye (SJS-DES) and non-Sjögren's Syndrome-related dry eye (Non-SJS-DES) populations. A total of 140 dry eye patients will be recruited and divided into two groups: 70 participants with SJS-DES and 70 with Non-SJS-DES. Participants will be randomly assigned into three groups: Sham+LA group (60 participants receiving 4 weeks of placebo laser acupuncture followed by 4 weeks of active laser acupuncture), LA+LA group (60 participants receiving 4 weeks of active laser acupuncture followed by another 4 weeks of active laser acupuncture), and a Waiting List group (20 participants receiving no laser acupuncture treatment). Each session will target the Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), and Quchi (LI11) acupoints bilaterally, performed twice a week. The total study period is 8 weeks, and the treatment efficacy will be assessed at the end of the 8-week treatment. The Waiting List group (20 participants) will not receive any laser acupuncture treatment during this period. Efficacy will be evaluated using the Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), Traditional Chinese Medicine (TCM) tongue diagnosis, TCM pulse diagnosis, TCM constitution questionnaire, TCM heart rate variability analysis, nailfold microcirculation assessment, and iris examination. This study aims to investigate the impact of laser acupuncture on dry eye symptom improvement and the potential markers that differentiate between SJS-DES and Non-SJS-DES patients. The goal is to develop a comprehensive integrated care model for early screening, diagnosis, and personalized treatment plans for Dry Eye Syndrome and Sjögren's Syndrome, achieving the ultimate objective of "Holistic Health Care."

Expected Results:

  1. Assess the therapeutic differences between Sham+LA and LA+LA groups in the SJS-DES population.
  2. Assess the therapeutic differences between Sham+LA and LA+LA groups in the Non-SJS-DES population.
  3. Evaluate the therapeutic differences between the SJS-DES and Non-SJS-DES populations.

Keywords: Dry eye syndrome, Sjögren's syndrome, Laser Acupuncture, GB20, BL2, LI4, LI11

Being tested
Laser acupuncture (LA), Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)
Keywords
Dry eye syndrome, Sjögren's syndrome, Laser Acupuncture, Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), Quchi (LI11)
Medical subject headings
Dry Eye Syndromes, Sjogren's Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laser acupuncture (LA)Other

    The RJ-Laser acupuncture device (Reimers \& Janssen GmbH, Waldkirch, Germany) is used with a laser wavelength of 810 nm (infrared). The Bahr frequency B3 is set at 2398 Hz, with an energy output of 400 mW, operating in intermittent pulse mode. Each acupoint is irradiated for 15 seconds. A total of 8 bilateral acupoints are treated per session, with a total treatment time of approximately 120 seconds.

  • Numerical Rating Scale (NRS)Diagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the Numerical Rating Scale (NRS).

  • Schirmer's testDiagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the Schirmer's test.

  • Ocular Surface Disease Index (OSDI)Diagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the OSDI test.

  • EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)Diagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the ESSPRI.

  • Traditional Chinese Medicine (TCM) tongue diagnosisDiagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the Traditional Chinese Medicine (TCM) tongue diagnosis.

  • Traditional Chinese Medicine (TCM) pulse diagnosisDiagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the Traditional Chinese Medicine (TCM) pulse diagnosis.

  • Traditional Chinese Medicine (TCM) constitution questionnaireDiagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the Traditional Chinese Medicine (TCM) constitution questionnaire.

  • Traditional Chinese Medicine (TCM) heart rate variability analysisDiagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the Traditional Chinese Medicine (TCM) heart rate variability analysis.

  • nailfold microcirculation assessmentDiagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the nailfold microcirculation assessment.

  • iris examinationDiagnostic test

    LA+LA group of SJS-DES, Sham+LA group of SJS-DES, LA+LA group of Non-SJS-DES, Sham+LA group of Non-SJS-DES and Waiting list will take the iris examination.

  • Sham Laser AcupunctureOther

    The RJ-Laser acupuncture device (Reimers \& Janssen GmbH, Waldkirch, Germany) is used with a laser wavelength of 810 nm (infrared). The Bahr frequency B3 is set at 2398 Hz, with an energy output of 400 mW, operating in intermittent pulse mode. Each acupoint is irradiated for 15 seconds. A total of 8 bilateral acupoints are treated per session, with a total treatment time of approximately 120 seconds.

    The sham laser acupuncture procedure follows the same process as the true laser acupuncture protocol, including the positioning, cleaning of acupoints, and wearing of protective goggles. However, no laser emission is delivered during the treatment. This ensures a consistent experience for the patient while maintaining the blinding integrity of the study.

Study groups in NCT06780293
Study groupRoleWhat they receive
LA+LA group of SJS-DESExperimentalLA+LA group of SJS-DES will receive laser acupuncture at acupoint GB20, BL2, LI4 and LI11 twice a week 8 weeks for efficacy evaluation. And we could use the Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), Traditional Chinese Medicine (TCM) tongue diagnosis, TCM pulse diagnosis, TCM constitution questionnaire, TCM heart rate variability analysis, nailfold microcirculation assessment, and iris examination for this purpose.
Receives: Other: Laser acupuncture (LA); Diagnostic Test: Numerical Rating Scale (NRS); Diagnostic Test: Schirmer's test; Diagnostic Test: Ocular Surface Disease Index (OSDI); Diagnostic Test: EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI); Diagnostic Test: Traditional Chinese Medicine (TCM) tongue diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) pulse diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) constitution questionnaire; Diagnostic Test: Traditional Chinese Medicine (TCM) heart rate variability analysis; Diagnostic Test: nailfold microcirculation assessment; Diagnostic Test: iris examination
Sham+LA group of SJS-DESSham comparatorSham+LA group of SJS-DES will receive sham acupuncture twice a week 4 weeks and then laser acupuncture at acupoint GB20, BL2, LI4 and LI11 twice a week 4 weeks for efficacy evaluation. And we could use the Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), Traditional Chinese Medicine (TCM) tongue diagnosis, TCM pulse diagnosis, TCM constitution questionnaire, TCM heart rate variability analysis, nailfold microcirculation assessment, and iris examination for this purpose.
Receives: Other: Laser acupuncture (LA); Diagnostic Test: Numerical Rating Scale (NRS); Diagnostic Test: Schirmer's test; Diagnostic Test: Ocular Surface Disease Index (OSDI); Diagnostic Test: EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI); Diagnostic Test: Traditional Chinese Medicine (TCM) tongue diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) pulse diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) constitution questionnaire; Diagnostic Test: Traditional Chinese Medicine (TCM) heart rate variability analysis; Diagnostic Test: nailfold microcirculation assessment; Diagnostic Test: iris examination; Other: Sham Laser Acupuncture
LA+LA group of Non-SJS-DESExperimentalLA+LA group of Non-SJS-DES will receive laser acupuncture at acupoint GB20, BL2, LI4 and LI11 twice a week 8 weeks for efficacy evaluation. And we could use the Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), Traditional Chinese Medicine (TCM) tongue diagnosis, TCM pulse diagnosis, TCM constitution questionnaire, TCM heart rate variability analysis, nailfold microcirculation assessment, and iris examination for this purpose.
Receives: Other: Laser acupuncture (LA); Diagnostic Test: Numerical Rating Scale (NRS); Diagnostic Test: Schirmer's test; Diagnostic Test: Ocular Surface Disease Index (OSDI); Diagnostic Test: EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI); Diagnostic Test: Traditional Chinese Medicine (TCM) tongue diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) pulse diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) constitution questionnaire; Diagnostic Test: Traditional Chinese Medicine (TCM) heart rate variability analysis; Diagnostic Test: nailfold microcirculation assessment; Diagnostic Test: iris examination
Sham+LA group of Non-SJS-DESSham comparatorSham+LA group of Non-SJS-DES will receive sham acupuncture twice a week 4 weeks and then laser acupuncture at acupoint GB20, BL2, LI4 and LI11 twice a week 4 weeks for efficacy evaluation. And we could use the Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), Traditional Chinese Medicine (TCM) tongue diagnosis, TCM pulse diagnosis, TCM constitution questionnaire, TCM heart rate variability analysis, nailfold microcirculation assessment, and iris examination for this purpose.
Receives: Other: Laser acupuncture (LA); Diagnostic Test: Numerical Rating Scale (NRS); Diagnostic Test: Schirmer's test; Diagnostic Test: Ocular Surface Disease Index (OSDI); Diagnostic Test: EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI); Diagnostic Test: Traditional Chinese Medicine (TCM) tongue diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) pulse diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) constitution questionnaire; Diagnostic Test: Traditional Chinese Medicine (TCM) heart rate variability analysis; Diagnostic Test: nailfold microcirculation assessment; Diagnostic Test: iris examination; Other: Sham Laser Acupuncture
Waiting listOtherGroup Waiting list will not receive any treatment at acupoint GB20, BL2, LI4 and LI11 twice a week 8 weeks for efficacy evaluation. And we could use the Numerical Rating Scale (NRS), Schirmer's test, Ocular Surface Disease Index (OSDI), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), Traditional Chinese Medicine (TCM) tongue diagnosis, TCM pulse diagnosis, TCM constitution questionnaire, TCM heart rate variability analysis, nailfold microcirculation assessment, and iris examination for this purpose.
Receives: Diagnostic Test: Numerical Rating Scale (NRS); Diagnostic Test: Schirmer's test; Diagnostic Test: Ocular Surface Disease Index (OSDI); Diagnostic Test: EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI); Diagnostic Test: Traditional Chinese Medicine (TCM) tongue diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) pulse diagnosis; Diagnostic Test: Traditional Chinese Medicine (TCM) constitution questionnaire; Diagnostic Test: Traditional Chinese Medicine (TCM) heart rate variability analysis; Diagnostic Test: nailfold microcirculation assessment; Diagnostic Test: iris examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Numerical Rating Scale (NRS)

    Numerical Rating Scale (NRS) is a tool for evaluating pain among the Dry eye syndrome (DES).

    Measured: one year

  2. Schirmer's test

    Schirmer's test is a tool for evaluating aqueous tear production among the Dry eye syndrome (DES).

    Measured: one year

  3. Ocular Surface Disease Index (OSDI)

    Ocular Surface Disease Index (OSDI) is a tool to rate the severity of dry eye disease among the Dry eye syndrome (DES).

    Measured: one year

Secondary outcomes (7)
  1. EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)

    EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) is a tool for evaluating the symptoms of SJS among the Dry eye syndrome (DES).

    Measured: one year

  2. Traditional Chinese Medicine (TCM) tongue diagnosis

    Traditional Chinese Medicine (TCM) tongue diagnosis is a tool for detecting tongue expression among the Dry eye syndrome (DES).

    Measured: one year

  3. Traditional Chinese Medicine (TCM) pulse diagnosis

    Traditional Chinese Medicine (TCM) pulse diagnosis is a tool for detecting tongue expression pulse pattern among the Dry eye syndrome (DES).

    Measured: one year

  4. Traditional Chinese Medicine (TCM) constitution questionnaire

    Traditional Chinese Medicine (TCM) constitution questionnaire is a tool for detecting the constitution among the Dry eye syndrome (DES).

    Measured: one year

  5. Traditional Chinese Medicine (TCM) heart rate variability analysis

    Traditional Chinese Medicine (TCM) heart rate variability analysis is a tool for detecting ratio between High-frequency (HF) activity and low-frequency (LF) activity among the Dry eye syndrome (DES).

    Measured: one year

  6. Nailfold microcirculation assessment

    Nailfold microcirculation assessment is a tool for detecting the status of nailfold microcirculation among the Dry eye syndrome (DES).

    Measured: one year

  7. Iris examination

    Iris examination is a tool for detecting the status of iris among the Dry eye syndrome (DES).

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jan 2025
  2. Study start3 Feb 2025
  3. Primary completion30 Apr 2025 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A total of 140 dry eye patients will be recruited and divided into two groups: 70 participants with SJS-DES and 70 with Non-SJS-DES. Participants will be randomly assigned into three groups: Sham+LA group (60 participants receiving 4 weeks of placebo laser acupuncture followed by 4 weeks of active laser acupuncture), LA+LA group (60 participants receiving 4 weeks of active laser acupuncture followed by another 4 weeks of active laser acupuncture), and a Waiting List group (20 participants receiving no laser acupuncture treatment).
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06780293
Sponsor's protocol ID
2024-11-008C
Acronym
LADESJS
Status last verified
Apr 2025
First submitted
13 Jan 2025
Last updated
9 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The decision to share individual participant data (IPD) is currently undecided due to ongoing discussions regarding data management, privacy concerns, and compliance with institutional and regulatory requirements. Additional considerations include the establishment of appropriate data-sharing agreements, ensuring participant confidentiality, and defining the scope and method of data access. Once these factors are thoroughly evaluated and addressed, a final decision regarding IPD sharing will be made in accordance with ethical guidelines and applicable regulations.

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Laser acupuncture (LA), Numerical Rating Scale (NRS) and Schirmer's test in people with Dry Eye Syndrome (DES) and Laser Acupuncture, run by Taipei Veterans General Hospital, Taiwan at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ching-Mao Chang, M.D., Ph.D. (886-28757453, 333, magicbjp@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numerical Rating Scale (NRS) (time frame: one year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in